Silexion Therapeutics announces 1-for-9 reverse share split

seekingalpha
23 Nov 2024
  • Silexion Therapeutics (NASDAQ:SLXN) has announced a 1-for-9 reverse share split of its ordinary shares.
  • The reverse share split will become effective after market close on November 27, 2024, and the company’s ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Global Market at market open on November 29, 2024.
  • The reverse share split is intended to enable SLXN to regain and maintain compliance with Nasdaq’s minimum bid price requirement.
  • Source: Press Release

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10